Delphia (USA)’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-18,282
| Closed | -$185K | – | 259 |
|
2022
Q4 | $185K | Sell |
18,282
-2,967
| -14% | -$30.1K | 0.21% | 210 |
|
2022
Q3 | $210K | Sell |
21,249
-28,989
| -58% | -$286K | 0.24% | 195 |
|
2022
Q2 | $535K | Buy |
50,238
+33,890
| +207% | +$361K | 0.37% | 73 |
|
2022
Q1 | $159K | Buy |
+16,348
| New | +$159K | 0.12% | 293 |
|